Equinom

Company Overview

Snapshot

Founded in January 2012 by Gil Shalev, Equinom operates with 11–50 employees. The company has raised $75.25 million across 5 funding rounds from 13 investors. In December 2022, Equinom secured funding led by Synthesis Capital to advance its plant-based nutrition initiatives.

Business overview

Equinom specializes in creating source ingredients for nutritious food by focusing on individual seed varieties. The company collaborates with the food and ingredient industries to custom-design ingredients and facilitate local sourcing. Utilizing AI and computational breeding, Equinom leverages the natural diversity in crops to develop a portfolio of non-GMO varieties. These seeds are engineered to meet the demands of the plant-based food industry, offering enhanced protein content, superior organoleptic qualities, and nutritional value, alongside traits that minimize processing. Equinom operates within the Agriculture & Food Technologies sector, with a focus on sustainable farming and sustainable proteins.

Strategic signal

In August 2024, Equinom made its AI-driven Manna Technology commercially available for high-protein pea production. This development signals a significant advancement in the company's ability to scale its proprietary breeding technology, offering a solution for the growing demand for plant-based protein ingredients and potentially transforming the efficiency and output of pea cultivation for the food industry.

Company Intelligence Q&A

What was a significant recent development for Equinom's technology?

In August 2024, Equinom announced the commercial availability of its AI-driven Manna Technology for high-protein pea production, enhancing its offerings for the plant-based food industry.

When did Equinom last raise funding and who were the lead investors?

In December 2022, Equinom secured funding led by Synthesis Capital. Bunge Ventures also participated in this round.

When did Equinom establish a new R&D center?

In October 2020, Equinom built a new R&D center to further its research and development capabilities in seed breeding.

Which investors participated in Equinom's June 2021 funding round?

In June 2021, Equinom received funding led by Phoenix Insurance, with additional participation from.

When did Equinom enter the US market?

In March 2020, Equinom entered the US market with its non-GMO seed breeding technology, expanding its global presence.